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Abstract: Pseudomonas syringae pv. actinidiae is an economically significant pathogen 
responsible for severe bacterial canker of kiwifruit (Actinidia sp.). Bacteriophages infecting 
this phytopathogen have potential as biocontrol agents as part of an integrated approach to 
the management of bacterial canker, and for use as molecular tools to study this bacterium. 
A variety of bacteriophages were previously isolated that infect P. syringae pv. actinidiae, 
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and their basic properties were characterized to provide a framework for formulation of these 
phages as biocontrol agents. Here, we have examined in more detail φPsa17, a phage with 
the capacity to infect a broad range of P. syringae pv. actinidiae strains and the only member 
of the Podoviridae in this collection. Particle morphology was visualized using cryo-electron 
microscopy, the genome was sequenced, and its structural proteins were analysed using 
shotgun proteomics. These studies demonstrated that φPsa17 has a 40,525 bp genome, is a 
member of the T7likevirus genus and is closely related to the pseudomonad phages φPSA2 
and gh-1. Eleven structural proteins (one scaffolding) were detected by proteomics and 
φPsa17 has a capsid of approximately 60 nm in diameter. No genes indicative of a lysogenic 
lifecycle were identified, suggesting the phage is obligately lytic. These features indicate 
that φPsa17 may be suitable for formulation as a biocontrol agent of P. syringae pv. actinidiae. 
Keywords: biocontrol agent; kiwifruit; canker; Pseudomonas syringae pv. actinidiae; 
bacteriophage; cryo-electron microscopy; single particle reconstruction; genomics; 
proteomics; vB_PsyP_phiPsa17 
 
1. Introduction 
Pseudomonas syringae pv. actinidiae has recently emerged as a significant global pathogen [1], 
responsible for the bacterial canker of kiwifruit (Actinidia sp.). P. syringae pv. actinidiae was initially 
determined to be the bacterium responsible for this disease in Japan in 1989 [2]. The pathogen was 
subsequently detected in a number of kiwifruit growing countries, but its impacts could be effectively 
managed [3–6]. In 2008 however, a highly aggressive genotype of P. syringae pv. actinidiae emerged 
and has been detected in various countries in Europe, Asia, South America and Australasia [7–14]. These 
new P. syringae pv. actinidiae isolates are more aggressive and difficult to manage, with gold kiwifruit 
(e.g., A. chinensis) being particularly susceptible, although the green varieties (e.g., A. deliciosa) are also 
sensitive [15]. In November 2010, this aggressive strain of P. syringae pv. actinidiae was first detected 
in New Zealand [16] and now is estimated to be present in 87% of the kiwifruit orchards [17]. During 
infection, P. syringae pv. actinidiae can enter the plant through natural openings and lesions and causes 
leaf spotting, brown discoloration of buds, canker exudates on trunks and twigs, cane leader dieback and 
in severe cases, plant death [18,19]. 
Currently in New Zealand, P. syringae pv. actinidiae infections are being managed using a variety of 
approaches, which range from orchard practices and hygiene, through to new plant varieties (e.g.,  
A. chinensis Gold3™) and streptomycin treatment [17]. Genetic analysis of the current worldwide 
pandemic strains demonstrates that they differ in only a few single nucleotide polymorphisms in their 
core genomes, with a variable content of genomic islands accounting for any major differences [20–24]. 
This relative homogeneity is suited for a phage therapy biocontrol approach, since the pathogen 
population is more easily targeted by specific phages [25,26]. Previously, we reported the isolation of a 
collection of ~250 phages that infect P. syringae pv. actinidiae [27]. Twenty four phages were analysed 
by host-range, cross-resistance profiling, negative staining and transmission electron microscopy,  
pulse-field gel electrophoresis and restriction digestion. The phages were all Caudovirales and 
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representatives of the three major phage morphological groups were identified (Myoviridae, Podoviridae 
and Siphoviridae). Nine Myoviridae genomes were sequenced, one was assembled and an automated 
annotation performed. The eight other Myoviridae genome sequences were mapped to this complete 
genome and showed that they are similar, yet distinct. It is evident that parallel and complementary 
strategies are required for the long-term response to P. syringae pv. actinidiae and phages might be part 
of the approach. A greater understanding of the disease pathology of P. syringae pv. actinidiae is also 
desired and could be improved by new genetic tools. Phages have traditionally provided many such 
advances in genetic manipulation, including transducing vectors, integrative elements, restriction 
enzymes and other enzymes for making mutations [28,29]. Therefore, detailed analysis of P. syringae 
pv. actinidiae phages may reveal useful tools to analyse their host. 
In this study, we have performed genomics, proteomics and morphological analyses of φPsa17. This 
phage was the only member of the Podoviridae that we isolated and was obtained from a wastewater 
sample in Tahuna, Dunedin, NZ, an area with no known or detected P. syringae pv. actinidiae [27]. The 
lack of P. syringae pv. actinidiae suggests that the native host of φPsa17 is another related bacterium. 
Indeed, φPsa17 was shown to have a broader host range than many of the other phages isolated in our 
original study, infecting Italian, Japanese and South Korean strains, and some isolates from pre-2008 
outbreaks in addition to other New Zealand pseudomonads [27]. Here, we show that φPsa17 is a member 
of the Caudovirales order, Podoviridae family, Autographivirinae subfamily and T7likevirus genus in 
terms of both genomic content, arrangement and capsid structure and protein composition. 
2. Materials and Methods 
2.1. Materials, Bacterial Strains and Culture Conditions 
Phages were grown on Pseudomonas syringae pv. actinidiae ICMP 18800, which was isolated from 
A. deliciosa kiwifruit plants in Paengaroa, New Zealand in 2010 [20]. Bacteria were grown in Nutrient 
Broth (NB; 5 g L−1 peptone, 3 g L−1 yeast extract, and 5 g L−1 NaCl) at 25 °C or on solid NB medium 
containing 1.5% (w v−1) agar. Unless stated otherwise, soft medium (top) agar (0.5% w v−1) was used 
for bacteriophage titrations. Phage buffer was composed of 10 mM Tris-HCl pH 7.4, 10 mM MgSO4, 
and 0.01% (w v−1) gelatin. The CHCl3 used in this study was saturated with sodium hydrogen carbonate. 
2.2. Phage Lysate Preparation 
Phage φPsa17 lysates were prepared by serial dilution in phage buffer and 100 μL was added to 4 mL 
soft NB agar containing 100 μL of a P. syringae pv. actinidiae overnight culture. The soft agar 
containing the phage and bacteria was poured onto plates and incubated overnight at 25 °C. Lysates were 
prepared from plates with almost confluent lysis by removing the soft agar overlay using a sterile glass 
slide and combining with 3 mL of phage buffer that was used to wash the plate. The agar was mixed 
with 500 μL CHCl3, vortexed for 2 min, incubated at room temperature for 30 min, centrifuged in 
fluorinated ethylene propylene (FEP) JA20 tubes at 2442 g for 30 min at 4 °C and the supernatant was 
retained. The phage lysates were stored at 4 °C with 100 μL CHCl3 added. Phage lysates were titred 
using the same double agar overlay method as described above. These lysates were used for DNA 
preparations, sequencing and inoculation of larger cultures for higher-purity and higher-titre preparations. 
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2.3. Phage Genome Sequencing, Assembly and Annotation 
DNA from φPsa17 was isolated as described previously and the concentration was determined using 
a nanodrop ND1000 [27]. The DNA was further purified and eluted using the column binding, washing 
and elution steps of the Qiagen DNeasy Blood & Tissue Kit (Venlo, The Netherlands). Genome 
sequencing was performed by New Zealand Genomics Ltd and the libraries were prepared using the 
Illumina TruSeq DNA Sample Preparation v2 kit (San Diego, CA, USA). Libraries were quantified using 
a Bioanalyzer 2100 DNA 1000 chip (Agilent; Santa Clara, CA, USA) and the Qubit Fluorometer using 
the dsDNABR kit (Life Technologies; Carlsbad, CA, USA). MiSeq 150 bp paired-end sequencing was 
performed and de-multiplexed using the ea-utils suite of tools [30]. The φPsa17 phage was assembled 
into one contig using 1,101,120 reads and Geneious v6.1.6 [31] (de novo assembly using default settings 
with increased sensitivity). The contig ends overlapped allowing a single circular phage scaffold 
assembly to be generated. The reads were mapped back to the assembly for validation and approximately 
4,100-fold coverage was achieved. The genome was linearised after identification of direct terminal 
repeats due to read ends and increased coverage across the repeat region (see Results and Discussion). 
Automated annotation of φPsa17 was performed using RAST [32], and the presence of tRNAs was 
assessed using tRNAscan-SE [33] and ARAGORN [34]. CDSs were further analysed using BLAST [35] 
with a particular focus on members of the related T7likevirus genus for manual curation. Putative phage 
promoters and RBSs were identified and then manually curated by extracting the 100 bp upstream of the 
predicted CDSs [36] and looking for motifs using MEME [37]. Rho-independent terminators were 
predicted using ARNold (Erpin and RNAmotif) [38–40]. The presence of putative P. syringae pv. 
actinidiae promoter sequences was investigated using BPROM (linear discriminant function (LDF) 
threshold ≥3) [41] and Neural Network Promoter Prediction (minimum promoter score 0.9) [42]. 
Pairwise phage comparisons were performed using blastn within Easyfig [43]. The φPsa17 genome has 
been deposited in GenBank under accession number KR091952. 
2.4. Purification of φPsa17 for Proteomics 
P. syringae pv. actinidiae was grown overnight in 20 mL NB and used to inoculate 500 mL of NB in 
a 2 L baffled flask. Bacteria were grown with shaking at 160 rpm at 25 °C until an OD600 ≈ 0.3  
(~5 × 108 cfu mL−1) and φPsa17 added at a multiplicity of infection (MOI) of 0.0001. Infection was 
continued for 5 h (160 rpm at 25 °C) and the culture stored at 4 °C overnight. For PEG precipitation, 
cultures containing φPsa17 were brought up to room temperature and 20 g of NaCl was added per 500 
mL culture and dissolved. Cultures were stored on ice for 1 h and cell debris was removed by 
centrifugation at 11,000 g for 10 min at 4 °C. The supernatant was decanted, PEG6000 was added  
(10% w v−1 final concentration), dissolved by stirring at room temperature and stored on ice overnight 
to precipitate the phage. The precipitate was pelleted by centrifugation at 11,000 g for 20 min at 4 °C, 
the supernatant discarded and the tubes dried by inversion for 5 min. The phage pellet was resuspended 
gently in 600 μL of phage buffer by soaking at room temperature for 1 h. The PEG and cell debris were 
extracted from the phage suspension by adding an equal volume of CHCl3, vortexing for 1 min and 
centrifuging at 4000 g for 15 min at 4 °C. The aqueous phase containing phages, was recovered. Phages 
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were titred and the protein concentration determined using the BCA Protein Assay Kit (Thermo Fisher 
Scientific; Waltham, MA, USA). 
Phages were further purified using a stepwise CsCl gradient based on a method previously  
described [44]. The gradients were prepared in Beckman SW32.1 tubes by subsequently underlaying  
1.5 mL of each 1.33, 1.45, 1.6 and 1.7 g/cm3 CsCl solution. Phages were gently added (11 mL, containing 
0.5 g/mL CsCl to avoid osmotic shock) on top of the 1.33 g/cm3 CsCl. The tubes were centrifuged at 
140,000 g for 3 h at 4 °C. The opalescent phage band was collected using a glass pasteur pipette and 
dialysed (1000 kDa MWCO), twice for 30 min and once overnight, against 250 volumes (500 mL) of 
distilled water to remove CsCl. Phages were concentrated by vacuum centrifugation for 2 h at medium 
temperature and the titre was determined. 
2.5. Proteomics of φPsa17 
Sample preparation: For proteomics of the structural phage proteins, purified phages were combined 
with 4 × SDS loading dye (40 mM Tris-HCl (pH 6.8), 40% glycerol, 4 mM EDTA, 2.5% SDS, 0.2 mg 
mL−1 bromophenol blue), boiled for 5 min and separated by 12% SDS-PAGE (polyacrylamide gel 
electrophoresis). The gel lane of separated φPsa17 proteins was fractionated into eight molecular weight 
fractions and subjected to in-gel digestion with trypsin [45] using a robotic workstation for automated 
protein digestion (DigestPro Msi, Intavis AG; Cologne, Germany). Extracted tryptic peptides were 
concentrated using a centrifugal vacuum concentrator. 
Protein identification by liquid chromatography-coupled tandem mass spectrometry (LC-MS/MS): 
The tryptic peptides of each fraction were reconstituted in 15 µL of 5% (v v−1) acetonitrile, 0.2% (v v−1) 
formic acid in water and 5 µL were injected per run into an Ultimate 3000 nano-flow uHPLC-System 
(Dionex Co, Thermo Fisher Scientific; Waltham, MA, USA) that was in-line coupled to the nanospray 
source of a LTQ-Orbitrap XL mass spectrometer (Thermo Scientific; Waltham, USA). Peptides were 
separated on an in-house packed emitter-tip column (75 µm ID PicoTip fused silica tubing (New 
Objectives, Woburn, MA, USA) filled with C-18 material (3 µm bead size) to a length of 12 cm). Each 
fraction was analysed twice using slightly different LC-MS/MS conditions to improve protein 
identification and sequence coverage. For the first analysis, acetonitrile (ACN) gradients were formed 
from 5% solvent B (0.2% (v v−1) formic acid in ACN) in solvent A (0.2% (v v−1) formic acid in water) 
over 30 min, followed by increasing solvent B first to 45% over 6 min and then to 90% over 5 min.  
All steps were performed at a flow rate of 500 nL min−1 and followed by column washing and  
re-equilibration. For the second analysis, the durations of the first (from 5% to 25% solvent B) and 
second (from 25% to 40% solvent B) step were changed to 60 min and 10 min, respectively. 
The orbitrap mass analyser was operated in a mass range between m/z 400 and 2000 at a resolution 
of 60,000 at m/z 400 for the acquisition of precursor ion spectra. Preview mode for FTMS master scan 
was enabled to generate the precursor mass lists. The strongest six (analysis 1) or eight (analysis 2) 
precursor ion signals were selected for CID (collision-induced dissociation)-MS/MS in the LTQ ion trap 
at a normalised collision energy of 35%. Dynamic exclusion was enabled with two repeat counts during 
90 s followed by an exclusion period of 120 s. 
Data analysis: Raw spectra were processed through the Proteome Discoverer software (Thermo 
Fisher Scientific, Waltham, MA, USA) using default settings to generate peak lists. Peak lists were then 
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searched against a combined amino acid sequence database containing all φPsa17 sequence entries 
(GenBank accession KR091952, 49 entries) integrated into the full SwissProt/UniProt sequence 
database (downloaded July 2014; 546,000 entries) using the Sequest HT (Thermo Fisher Scientific; 
Waltham, MA, USA), Mascot (www.matrixscience.com) and MS Amanda [46] search engines. The 
same search settings were used for all three search engines allowing for semi-tryptic cleavages with a 
maximum of three missed cleavage sites and carboxyamidomethyl cysteine, oxidised methionine and 
deamidated asparagine and glutamine as variable modifications. The mass tolerance threshold was  
10 ppm and 0.8 Da for precursor ions and fragment ions respectively. 
The Percolator algorithm [47] was used to estimate the False Discovery Rate (FDR). Peptide hits 
were filtered for a strict FDR of q < 0.01. Additional peptide score filters for each search engine were 
applied to eliminate very low scoring peptide hits that may have passed the Percolator FDR filter. The 
following score thresholds for positive peptide identification were applied: Mascot peptide score of >20, 
MS Amanda score >100 and the default charge state (z)-dependent Sequest HT cross correlation scores 
(XCorr) that is 2.0 (z = 2), 2.25 (z = 3), 2.5 (z = 4), 2.75 (z = 5) and 3.2 for all other charge states. We 
only accepted protein identifications with two or more significant peptide hits that were consistently 
assigned to the same protein by all three search engines. 
2.6. Purification of φPsa17 for Cryo-Electron Microscopy 
Phage lysates were prepared as described in Section 2.2, with the exception that 2.5 mL of NB with 
0.75% w v−1 agar was used in the top overlay and the harvested plates were rinsed with 1 mL of phage 
buffer. Multiple samples were prepared and pooled to generate 2 × 11 mL of high-titre phage stock that 
was then further purified using CsCl gradients as described in Section 2.4. The phages were dialysed 
(3.5 kDa MWCO) once for 8 h and once overnight in 800 mL water to remove CsCl. 
2.7. Transmission Electron Microscopy and Cryo-Electron Microscopy 
High-titre phage lysates were prepared for transmission electron microscopy (TEM) on 300-mesh 
copper grids carbon coated and stained with 2% phosphotungstic acid solution (pH 7) for 1 min, as 
described previously [27]. Residual liquid was blotted away with filter paper. Transmission electron 
micrographs were recorded using a Philips CM100 TEM (Philips/FEI Corporation, Eindhoven, The 
Netherlands) operated at 100 kV at a magnification of 66,000. 
Cryogenic specimens were prepared by first applying 3 µL of purified virus on glow discharged 
Quantifoil holey carbon grids (Quantifoil Micro Tools GmbH, Grossloebichau/Jena, Germany). The 
excess buffer was blotted and the grid was flash plunged into liquid ethane using a Leica KF80 cryo 
fixation device (C. Reichert Optische Werke AG, Vienna, Austria). Frozen-hydrated specimens were 
stored in liquid nitrogen until loaded onto a Gatan 914 Cryoholder (Pleasanton, CA, USA). A JEOL 
JEM2200FS microscope (JEOL Ltd, Tokyo, Japan) operated at 200 kV was used for visualisation using 
minimal dose conditions with an electron dose less than 20 electrons/Å2. An in-column omega energy 
filter was used to improve image contrast by zero-loss filtering with a slit width of 25 eV. Automated 
data collection was carried out using SerialEM software [48]. The micrographs were recorded at a 
defocus between 1 and 3 µm, on a 4 × 4 k CMOS camera (TVIPS; Gauting, Germany) at a calibrated 
magnification of 50,000 corresponding to a pixel size of 3.12 Å. 
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Image processing. Individual phage particles were selected from micrographs using the E2BOXER 
programme [49]. Contrast Transfer Function parameters were calculated using CTFFIND3 [50], and 
micrographs with poor CTF estimates were discarded. Orientation, classification and refinement were 
done using Relion [51]. The resultant map was visualised using Chimera [52]. 
3. Results and Discussion 
3.1. Podovirus φPsa17 Genome Sequence 
φPsa17 was identified as a member of the Caudovirales order and Podoviridae family when observed 
by negative staining and transmission electron microscopy (Figure 1A,B). Plaques formed by φPsa17 
are large and clear with a turbid ring on 0.5% agar, with a total diameter of ~4–5 mm (Figure 1C).  
To characterise φPsa17, which was the only podovirus we previously isolated that infected P. syringae 
pv. actinidiae, genome sequencing was performed. The genome was sequenced using Illumina MiSeq 
(150 bp paired-end) and assembled into a linear genome with overlapping ends. By mapping the reads 
back to a circularised assembly, we observed an increased read depth in one region, indicating possible 
terminal redundancy. Interrogation of the read mapping revealed defined ends with increased sequence 
depth, which enabled the prediction that the genome was linear dsDNA with two 242 bp terminal repeats. 
 
Figure 1. (a) and (b) Transmission electron micrographs of φPsa17 by negative stained TEM; 
(c) Plaque morphology of φPsa17 on P. syringae pv. actinidiae ICMP18800 in nutrient broth 
with 0.5% agar; In (a) and (b) the scale bars represent 200 nm and 50 nm, respectively. 
The genome is 40,525 bp, linear, terminally redundant and has a 57% G + C content (Figure 2A,B). 
The genome was annotated, indicating the presence of 49 putative coding sequences (CDSs) (Table 1). 
φPsa17 contains no predicted tRNAs, which might be explained by its G + C content being similar to 
the host bacterium (57% vs. 58% for P. syringae pv. actinidiae). Interestingly, we recently sequenced 
φPsa374, a Myoviridae that infected P. syringae pv. actinidiae, which had a G + C content of 47.4% and 
contained 11 tRNAs [27]. 
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Figure 2. (a) The φPsa17 genome sequence and organisation is similar to members of the 
T7likevirus genus. The linear genome is 40,525 bp with terminal repeats (orange arrows). 
Predicted CDS are shown as arrows in cyan (or purple/pink if identified by proteomics).  
A putative Pseudomonas promoter early in the genome is indicated (dark blue triangle) and 
11 predicted phage RNAP-dependent promoters are depicted (green triangles). Four putative 
Rho-independent transcriptional terminators are shown (red triangles). Putative classes of 
genes (I, II & III), based on both homologues in T7 and genome organisation [53], are 
indicated and locus tags provided. “Coverage” indicates peptide mapping identified by 
proteomics (linear scale); (b) Expanded view of the structural proteome mapping data with 
“coverage” on a log scale; Images in (a) and (b) were prepared using Geneious v8.1.2 [31] 
and Adobe Illustrator; Sequence logos of the (c) 11 phage promoters and (d) 47 ribosome 
binding sites that were predicted. Logos were generated using MEME [37]. 
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Table 1. Putative genes of φPsa17 and their homologues in T7 and conserved domains. 
Locus Tag T7 Homologue Description Start End Length (bp) Domains or PHA# 
VO98_005  hypothetical 993 1262 270  
VO98_010  hypothetical 1259 1513 255  
VO98_015  hypothetical 1513 1710 198  
VO98_020  hypothetical 1715 1990 276  
VO98_025  hypothetical 2078 2557 480  
VO98_030  hypothetical 2588 3124 537  
VO98_035  hypothetical 3121 3825 705 Pfam13640 
VO98_040  hypothetical 3825 4028 204  
VO98_045  hypothetical 4030 4470 441  
VO98_050 gp1 
DNA-directed RNA  
polymerase (EC 2.7.7.6) 
4598 7255 2658 PHA00452 
VO98_055 gp1.1 hypothetical 7269 7406 138  
VO98_060  hypothetical 7403 7675 273  
VO98_065  hypothetical 7675 8061 387  
VO98_070 gp1.3 ATP-dependent DNA ligase 8073 9137 1065 PHA00454 
VO98_075 gp1.6 hypothetical 9331 9588 258 PHA00455 
VO98_080  hypothetical 9585 10,232 648 
ABC_ATPase 
superfamily 
VO98_085 gp2 host RNA polymerase inhibitor 10,229 10,396 168 PHA00457 
VO98_090  hypothetical 10,393 10,758 366  
VO98_095 gp2.5 T7-like ssDNA-binding 10,812 11,513 702 PHA00458 
VO98_100 gp3 
T7-like endonuclease  
(EC 3.1.21.2) 
11,513 11,956 444 
Phage_endo_I 
superfamily 
VO98_105 gp3.5 
lysozyme, N-acetylmuramoyl-L-
alanine amidase (EC 3.5.1.28) 
11,959 12,399 441 PGRP superfamily 
VO98_110  hypothetical 12,469 13,008 540 PolyA_pol superfamily 
VO98_115 gp4 T7-like DNA primase/helicase 12,995 14,686 1692  
VO98_120  hypothetical 14,705 14,902 198  
VO98_125  hypothetical 14,971 15,480 510  
VO98_130 gp5 
T7-like DNA Polymerase  
(EC 2.7.7.7) 
15,491 17,638 2148 
DNA_pol_A 
superfamily 
VO98_135  hypothetical 17,651 18,031 381  
VO98_140 gp5.7 hypothetical 18,024 18,233 210 PHA00422 
VO98_145 gp6 exonuclease 18,230 19,174 945 PHA00439 
VO98_150 gp6.5 hypothetical 19,243 19,485 243 DUF2717 
VO98_155 gp6.7 T7 virion protein 19,488 19,760 273 PHA00441 
VO98_160 gp7 hypothetical 19,757 20,200 444 PHA01807 
VO98_165 gp7.3 tail assembly 20,172 20,474 303 PHA00437 
VO98_170 gp8 
collar/T7-like  
head-to-tail connector 
20,489 22,120 1632 PHA00670 
VO98_175 gp9 capsid and scaffold 22,189 23,064 876 PHA00435 
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Table 1. Cont. 
Locus Tag T7 Homologue Description Start End Length (bp) Domains or PHA# 
VO98_180 gp10 major capsid protein 23,164 24,207 1044 
PHA00201 (PHA02004 
superfamily) 
VO98_185 gp11 T7-like tail tubular protein A 24,271 24,858 588 PHA00428 
VO98_190 gp12 T7-like tail tubular protein B 24,868 27,294 2427  
VO98_195 gp13 protein inside capsid A 27,353 27,787 435 PHA00432 
VO98_200 gp14 protein inside capsid B 27,798 28,385 588 PHA00101 
VO98_205 gp15 protein inside capsid C 28,378 30,594 2217 PHA00431 
VO98_210 gp16 protein inside capsid D 30,607 34,785 4179 PHA00638 
VO98_215 gp17 tail fibre 34,848 36,677 1830 PHA00430 
VO98_220  hypothetical 36,717 37,073 357  
VO98_225 gp17.5 holin, class II 37,073 37,288 216 PHA00426 
VO98_230 gp18 
T7-like DNA packaging protein 
A, small terminase subunit 
37,285 37,542 258 PHA00425 
VO98_235 gp18.5 
endopeptidase (EC 3.4.-.-), 
lambda Rz-like 
37,542 37,991 450 PHA00276 
VO98_240 gp19 
DNA packaging, large  
terminase subunit 
37,991 39,739 1749 Pfam03237 
VO98_245 gp19.5 hypothetical 39,919 40,092 174  
3.2. Transcriptional Organisation of the φPsa17 Genome 
The φPsa17 genome has genetic and organisational similarity to other members of the 
Autographivirinae subfamily and T7likevirus genus of phages (see Section 3.3). Based on the similarity 
to T7, we have proposed an organisation of the φPsa17 genome into three classes (I, II and III), 
representing the early, DNA metabolism and morphogenesis genes, respectively (Figure 2A) [53]. DNA 
injection is likely to occur in a similar manner to T7 and involve a first stage where ~850 bp is injected. 
One promoter that is potentially recognised by the P. syringae pv. actinidiae RNAP was identified in 
this early genomic region (positions 610–637; TTGACA-N16-TAAGA (Figure 2A; dark green triangle). 
This might be a strong promoter since a 16 nt spacing in Pseudomonas aeruginosa promoters enhances 
transcription [54]. Visual inspection of the φPsa17 genome identified a TTGACA-N18-TATGCG 
sequence (position 275–304) that might also be involved in initiating host-dependent transcription of the 
early genes. These host promoters are likely to act similarly to the three major Escherichia coli-
dependent promoters (A1-A3) in T7 to assist in the expression, and transcription-dependent 
translocation, of a further ~7 kb of the phage genome into the host bacterium, which consists of the class 
I early genes [53]. 
Eleven putative phage promoters were identified upstream of CDSs in φPsa17 (Figure 2A,C; green 
triangles), and are predicted to drive the expression of the class II and III genes. A sequence logo of 
these phage RNA polymerase (RNAP)-dependent promoters was generated, revealing the 21 bp 
consensus 5′-TTAAAAACCCTCACTATGGCT-3′ (Figure 2C). This promoter is similar to the 
consensus identified by Kovalyova and Kropinski for a related Pseudomonas putida phage gh-1  
(5′-TAAAAACCCTCACTRTGGCHSCM-3′) [55]. 
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An early CDS, locus tag VO98_050, encodes a DNA-dependent RNA polymerase (EC 2.7.7.6), 
which is the equivalent of gene 1 in E. coli phage T7 and is likely to be responsible for transcription 
from these phage promoters. Based on the similarity to T7, it is probable that the φPsa17 RNAP drives 
the translocation of the remainder of the genome into P. syringae pv. actinidiae. One reason for this 
multi-stage slow genome injection in T7 is to enable the production of defense proteins, in particular 
gp0.3 (Ocr), which mimics DNA and inhibits Type I restriction endonucleases [56]. We did not detect a 
homologue of gp0.3 in φPsa17, but it is possible that other poorly characterised class I and II genes 
might be performing similar functions (Table 1). Using structural searches (Phyre2 [57]) and HMM 
approaches (Phmmer [58]) on VO98_005 to VO98_045, we were unable to predict any additional 
domains for these predicted proteins. The shift from class II to III gene expression requires the action  
of gene 3.5 in T7 (aka lysozyme) [53] and φPsa17 possesses a homologue (VO98_105). Finally,  
four putative transcriptional terminators were detected and, like T7, “good” ribosome binding sites  
were detected upstream of almost all (i.e., 47) of the CDSs and had the consensus 5′-AAGGAG-3′ 
(Figure 2C). Therefore, the genome organisation of φPsa17 is highly similar to T7 and other close 
T7likevirus relatives (see Section 3.3). 
3.3. φPsa17 is a T7likevirus Similar to φPSA2 and gh-1 
Both the organisation and sequence similarity of the genome to existing phages strongly support the 
assignment of φPsa17 as a member of the T7likevirus genus. φPsa17 is highly similar to the well-annotated 
P. putida phage gh-1 (93% nt identity) (Figure 3) [55]. However, φPsa17 has an additional ~3.5 kb in 
the early region, after the terminal repeat and prior to the T7-like RNA polymerase (gene 1). Most 
members of the T7likevirus genus have genes in this region and the absence of genes in gh-1 is the 
exception [55]. Surprisingly, φPsa17, which was the first podovirus isolated that infects P. syringae pv. 
actinidiae [27], is nearly identical in terms of organisation and sequence (96% nt identity) to a recently 
sequenced P. syringae pv. actinidiae phage, φPSA2 (Figure 3) [59]. Both phages were isolated from 
sewerage, φPsa17 in Dunedin, New Zealand [27] and φPSA2 from Rome, Italy [59]. There are a number 
of differences between the two phages. Firstly, each phage has a single CDS that is absent in the other 
genome. The first CDS in φPsa17 (VO98_005) is absent in both φPSA2 and phage gh-1. This is a 
hypothetical protein with no known function, but homologues are present in other phages that infect 
members of the Enterobacteriaceae. The most closely related protein is encoded from the chromosome 
of Sinorhizobium meliloti AK83. Conversely, φPSA2 contains a gene (locus tag HL07_gp12; orf12 [59]) 
that is absent from φPsa17 (and gh-1). The function of this protein is unknown and no similar proteins 
were detected using tBLASTn. Another CDS of interest from the comparative analysis (Figure 3) is 
φPsa17 VO98_135, which appears different from those present in φPSA2 and gh-1. However, this is an 
artifact of the cut-off in Figure 3 and these genes are homologues of unknown function (φPSA17 cf. 
φPSA2 (38% identity/54% similarity) and φPSA17 cf. gh-1 (52% identity/69% similarity) at amino acid 
level). Finally, VO98_215 (T7 genes 17) and VO98_220 (hypothetical) from φPsa17 are conserved with 
φPSA2, but gh-1 is less conserved, particularly at the C-terminus of VO98_215. This is consistent with 
the annotation of VO98_215 as the phage tail fibre protein, since gh-1 has a different host (P. putida) 
compared with the P. syringae pv. actinidiae phages φPsa17 and φPSA2. The function of VO98_220 is 
unknown, but interestingly, it is also conserved in P. syringae pv. actinidiae myophage φPsa374  
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(locus tag CF96_gp141) [27]. In summary, φPsa17 is a member of the Autographivirinae subfamily and 
T7likevirus genus in terms of genomic content and organisation. 
 
Figure 3. Genome comparison of P. syringae pv. actinidiae φPsa17 with φPSA2 and  
P. putida gh-1 phages. Pairwise phage comparisons were performed using blastn within 
Easyfig and the grayscale indicates genes with 84%–100% nt identity [43]. Classes of genes 
and their T7-homologues are provided (as shown in Figure 2). Genes present in one genome, 
but lacking or having lower than 84% identity in others, lack gray regions indicating identity. 
Genes discussed in the text are outlined in black and the locus tags provided. The 
conservation of terminal repeats is visible as the large crossed gray lines. Accession numbers 
of input genomes were; φPsa17 (KR091952), φPSA2 (NC_024362) [59] and P. putida gh-1 
(NC_004665) [55]. 
3.4. Structural Proteome of φPsa17 
To understand how the genomic organisation relates to the phage structure, we analysed the structural 
proteins of purified φPsa17 phage particles using a gel-based shotgun proteomics approach. Eleven 
proteins were identified as structural proteins present in the φPsa17 preparations (Table 2). Each of these 
protein sequences was covered by more than 50% and at least 8 unique peptides. Mapping these to the 
translated CDSs highlighted the genes encoding the structural proteins and also indicated the abundance 
of the peptides detected (Figure 2A,B; purple genes and gray peptide coverage). E. coli phage T7 has 10 
different proteins expressed as part of the class III genes and present in the mature phage structure [53]. 
Homologues of all of the T7 structural proteins were identified in the φPsa17 genome (Figure 2A & B) 
and by the proteome analysis (Tables 1 & 2). The major capsid protein VO98_180 (T7 gp10), the internal 
core proteins VO98_200, VO98_205 and VO98_210 (T7 gp14, gp15 and gp16 respectively), the  
head-tail connector VO98_170 (T7 gp8), the non-essential head-tail protein VO98_155 (T7 gp6.7), the 
tail proteins VO98_185, VO98_190 and VO98_165 (T7 gp12, gp12 and gp7.3 respectively) and the tail 
fibre protein VO98_215 (T7 gp17) were all detected. VO98_180 appears to be the most abundant 
protein, consistent with its assignment as the major capsid protein, equivalent to gp10A in T7, which is 
present in ~415 copies [60]. No frame-shifted major capsid protein was detected (i.e., the equivalent of 
T7 gp10B). The only other protein detected in φPsa17 was VO98_175 (T7 gp 9), albeit at the lowest 
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sequence coverage (Table 2). Gp9 is a scaffolding protein present in T7 procapsids, but absent in mature 
virions [61]. Detection of VO98_175 suggested that our samples included some procapsids, some of 
which were detected by cryo-EM (Figure 4A & B). E. coli T7 and P. putida gh-1 both use lipopolysaccharide 
for attachment via the tail fibres, but the receptor for φPsa17 VO98_215 is unknown. In T7, tail (gp11 
and gp12) attachment results in ejection of gp7.3 and gp6.7 into the outer membrane [53]. Upon 
irreversible binding, gp14, gp15 and gp16 form a channel across the cell envelope and are involved in 
the genome ratcheting mechanism to bring the first ~850 bp of T7 into the bacterium [53,62]. Taken 
together, the proteome analysis demonstrates that φPsa17 particles consist of the same structural protein 
complement as phage T7 and host attachment and infection are most likely analogous to T7. 
Table 2. Identified structural proteome of φPsa17 phage particles. 
Locus Tag Description/T7 Homologue 
Unique 
Peptides b 
Total 
Peptides 
Total 
Mascot 
Total 
Amanda 
Total 
Sequest 
Total 
PSMs c 
Coverage 
(%) 
VO98_155 virion protein, gp6.7 16 18 16 14 18 426 80.00 
VO98_165 tail assembly protein, gp7.3 8 10 10 6 10 140 60.00 
VO98_170 collar/T7-like head-to-tail joining protein, gp8 72 112 101 70 110 2998 85.08 
VO98_175 capsid and scaffold, gp9a 20 27 24 16 25 468 52.92 
VO98_180 major capsid protein, gp10 151 215 192 69 195 7780 99.14 
VO98_185 tail protein/T7-like tail tubular protein A, gp11 14 18 16 12 15 560 56.92 
VO98_190 tail protein/T7-like tail tubular protein B, gp12 42 56 53 45 54 1366 71.66 
VO98_200 protein inside capsid B, gp14 30 64 56 34 61 866 84.10 
VO98_205 protein inside capsid C, gp15 141 221 196 131 201 4467 95.66 
VO98_210 protein inside capsid D, gp16 153 232 209 165 222 4282 86.28 
VO98_215 tail fibres, gp17 79 108 93 66 103 3155 92.28 
a In E. coli phage T7, gp9 is a scaffolding protein not present in the mature phage particle; b The coverage of 
each protein is given by the number of significantly identified unique peptides, the total number of peptides 
assigned and by each of the search engines (Mascot, MS Amenda, HT Sequest); c The number of acquired 
peptide spectra per protein (PSMs - peptide spectral matches) resulting in the identified sequence coverage 
(coverage (%)). 
3.5. Cryo-TEM Structure of φPsa17 
The genome and proteome analyses indicated that φPsa17 is a T7likevirus with similar proteins to T7 
contributing to the mature virion (Figure 2). Indeed, the initial negative stained TEM results (Figure 1) 
indicated that φPsa17 was a member of the Podoviridae with a similar morphology and size to T7.  
A great deal of cryo-EM studies were previously published that describe the structure of the T7 phage 
capsid [61,63,64], the process of capsid maturation [61,65], and the conformational changes associated 
with genome delivery [62]. To confirm the structural morphology of φPsa17 at a higher resolution, we 
visualised the purified virus in a frozen hydrated state. From a total of over 200 micrographs we selected 
~1400 individual particle images (e.g., Figure 4A,B). The images show capsids about 60 nm in diameter, 
some of them showing a clearly visible tail (Figure 4B). A small number of empty capsids were also 
present in the sample (Figure 4B). Based on icosahedral symmetry, we calculated a three dimensional 
map of the capsid to a resolution of 2.2 nm, based on the 0.143 Fourier shell correlation criterion [66]. 
The map presents a number of 12 prominent pentons and 20 hexons arranged in a T = 7l capsid of  
Viruses 2015, 7 3374 
 
~25 nm thickness and a maximum diameter of 60 nm. As expected based on the genome similarity, our 
reconstruction shows features similar to the T7 phage mature capsid as reported in previous studies. 
 
Figure 4. Single particle reconstructions of φPsa17. (a) Representative cryo-EM field of 
view. Scale bar 200 nm; (b) A gallery of cryo-EM images representing full capsids (left), 
capsids with visible tails (middle), and empty capsids (right), scale bar 20 nm; (c) 3D 
reconstruction of the φPsa17 phage capsid, scale bar 20 nm. 
4. Conclusions 
In this study we have further characterised a podovirus that infects the economically important 
kiwifruit pathogen, P. syringae pv. actinidiae. A combination of next-generation genome sequencing, 
shotgun proteomics of structural proteins and morphological analysis by cryo-EM and single particle 
reconstruction revealed that φPsa17 is a member of the T7likevirus genus that is related to the previously 
sequenced pseudomonad phages φPSA2 and gh-1. T7 phages are typically thought to be obligately  
lytic [53], which is desirable for the development of a phage biocontrol agent. Furthermore, analysis of 
the φPsa17 genome did not reveal any genes involved in a lysogenic lifecycle or bacterial virulence 
genes. Our previous work indicated that φPsa17 has a relatively broad host-range, infecting P. syringae 
pv. actinidiae strains from New Zealand, Italy, Japan and South Korea and some less virulent (LV) strains 
from New Zealand [27], which are distinct from the virulent P. syringae pv. actinidiae isolates [20,24]. 
In addition, φPsa17 can infect, albeit with a lower efficiency, a non-pathogenic P. fluorescens isolate 
(ABAC62) that might be able to function as a carrier (or phage amplifying) strain [27]. Together, these 
features of φPsa17 indicate that it might have future potential as a biocontrol agent. 
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